The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Carcinoma in Situ; Neoplasm Invasiveness; Deoxycytidine; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Administration, Intravesical; Aged; Aged, 80 and over; Middle Aged; Female; Male
PubMed ID
40737582
PubMed Central ID
PMC12622271
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal